These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 9736425)
1. Expression of p21 (Waf1/Cip1) in head and neck cancer in relation to proliferation, differentiation, p53 status and cyclin D1 expression. van Oijen MG; Tilanus MG; Medema RH; Slootweg PJ J Oral Pathol Med; 1998 Sep; 27(8):367-75. PubMed ID: 9736425 [TBL] [Abstract][Full Text] [Related]
2. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features. Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796 [TBL] [Abstract][Full Text] [Related]
3. Aberrant p21(CIP1/WAF1) protein accumulation in head-and-neck cancer. Erber R; Klein W; Andl T; Enders C; Born AI; Conradt C; Bartek J; Bosch FX Int J Cancer; 1997 Aug; 74(4):383-9. PubMed ID: 9291426 [TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 and p21 in ulcerative colitis-related inflammation and epithelial neoplasia: a study of aberrant expression and underlying mechanisms. Wong NA; Mayer NJ; Anderson CE; McKenzie HC; Morris RG; Diebold J; Mayr D; Brock IW; Royds JA; Gilmour HM; Harrison DJ Hum Pathol; 2003 Jun; 34(6):580-8. PubMed ID: 12827612 [TBL] [Abstract][Full Text] [Related]
5. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival. Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K; Kosma VM Br J Cancer; 1999 Aug; 80(12):2001-7. PubMed ID: 10471053 [TBL] [Abstract][Full Text] [Related]
6. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer. Ralhan R; Agarwal S; Mathur M; Wasylyk B; Srivastava A Clin Cancer Res; 2000 Jun; 6(6):2440-7. PubMed ID: 10873097 [TBL] [Abstract][Full Text] [Related]
7. p21, p27, cyclin D1, and p53 in rectal cancer: immunohistology with prognostic significance? Schwandner O; Bruch HP; Broll R Int J Colorectal Dis; 2002 Jan; 17(1):11-9. PubMed ID: 12018448 [TBL] [Abstract][Full Text] [Related]
8. Perifosine, a novel alkylphospholipid, induces p21(WAF1) expression in squamous carcinoma cells through a p53-independent pathway, leading to loss in cyclin-dependent kinase activity and cell cycle arrest. Patel V; Lahusen T; Sy T; Sausville EA; Gutkind JS; Senderowicz AM Cancer Res; 2002 Mar; 62(5):1401-9. PubMed ID: 11888912 [TBL] [Abstract][Full Text] [Related]
9. Concerted overexpression of the genes encoding p21 and cyclin D1 is associated with growth inhibition and differentiation in various carcinomas. de Jong JS; van Diest PJ; Michalides RJ; Baak JP Mol Pathol; 1999 Apr; 52(2):78-83. PubMed ID: 10474686 [TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of the expression of cell cycle regulating proteins: cyclin D1, P53 and P21 (WAF1) in colorectal cancer. Pasz-Walczak G; Kordek R Pol J Pathol; 2000; 51(2):63-9. PubMed ID: 10974928 [TBL] [Abstract][Full Text] [Related]
11. Expression of cyclin dependent kinase inhibitor p21waf1/cip1 in premalignant and malignant oral lesions: relationship with p53 status. Agarwal S; Mathur M; Shukla NK; Ralhan R Oral Oncol; 1998 Sep; 34(5):353-60. PubMed ID: 9861340 [TBL] [Abstract][Full Text] [Related]
12. EGFR, HER-2/neu, cyclin D1, p21 and p53 in correlation to cell proliferation and steroid hormone receptor status in ductal carcinoma in situ of the breast. Lebeau A; Unholzer A; Amann G; Kronawitter M; Bauerfeind I; Sendelhofert A; Iff A; Löhrs U Breast Cancer Res Treat; 2003 May; 79(2):187-98. PubMed ID: 12825853 [TBL] [Abstract][Full Text] [Related]
13. Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells. Di Gennaro E; Barbarino M; Bruzzese F; De Lorenzo S; Caraglia M; Abbruzzese A; Avallone A; Comella P; Caponigro F; Pepe S; Budillon A J Cell Physiol; 2003 Apr; 195(1):139-50. PubMed ID: 12599217 [TBL] [Abstract][Full Text] [Related]
14. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis. Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941 [TBL] [Abstract][Full Text] [Related]
15. p21WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma. Nemes JA; Nemes Z; Márton IJ J Oral Pathol Med; 2005 May; 34(5):274-9. PubMed ID: 15817070 [TBL] [Abstract][Full Text] [Related]
16. Expression of p21WAF1/CIP1 is unrelated to p53 tumour suppressor gene status in oral squamous cell carcinomas. Yook JI; Kim J Oral Oncol; 1998 May; 34(3):198-203. PubMed ID: 9692054 [TBL] [Abstract][Full Text] [Related]
17. A clinicopathological study of p53, p21 (WAF1/CIP1) and cyclin D1 expression in human prostate cancers. Shiraishi T; Watanabe M; Muneyuki T; Nakayama T; Morita J; Ito H; Kotake T; Yatani R Urol Int; 1998; 61(2):90-4. PubMed ID: 9873247 [TBL] [Abstract][Full Text] [Related]
18. p21WAF1/Cip1 is associated with cyclin D1CCND1 expression and tubular differentiation but is independent of p53 overexpression in human breast carcinoma. Rey MJ; Fernández PL; Jares P; Muñoz M; Nadal A; Peiró N; Nayach I; Mallofré C; Muntané J; Campo E; Estapé J; Cardesa A J Pathol; 1998 Mar; 184(3):265-71. PubMed ID: 9614378 [TBL] [Abstract][Full Text] [Related]
19. Expression of p21/waf1 in oral squamous cell carcinomas--correlation with p53 and mdm2 and cellular proliferation index. Ng IO; Lam KY; Ng M; Regezi JA Oral Oncol; 1999 Jan; 35(1):63-9. PubMed ID: 10211312 [TBL] [Abstract][Full Text] [Related]
20. Expression of p53 and p21CIP1/WAF1 proteins in oral epithelial dysplasias and squamous cell carcinomas. Kudo Y; Takata T; Ogawa I; Sato S; Nikai H Oncol Rep; 1999; 6(3):539-45. PubMed ID: 10203588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]